1. Home
  2. FUNC vs TENX Comparison

FUNC vs TENX Comparison

Compare FUNC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUNC

First United Corporation

HOLD

Current Price

$45.14

Market Cap

283.6M

Sector

Finance

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$13.78

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUNC
TENX
Founded
1900
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.6M
317.8M
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
FUNC
TENX
Price
$45.14
$13.78
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
23.5K
1.4M
Earning Date
04-20-2026
05-15-2026
Dividend Yield
2.80%
N/A
EPS Growth
19.68
N/A
EPS
1.90
N/A
Revenue
$18,426,000.00
N/A
Revenue This Year
$13.05
N/A
Revenue Next Year
$6.56
N/A
P/E Ratio
$43.98
N/A
Revenue Growth
4.01
N/A
52 Week Low
$32.51
$5.80
52 Week High
$46.30
$19.40

Technical Indicators

Market Signals
Indicator
FUNC
TENX
Relative Strength Index (RSI) 58.54 42.05
Support Level $36.38 $13.13
Resistance Level $46.27 $14.15
Average True Range (ATR) 1.19 1.19
MACD -0.10 -0.36
Stochastic Oscillator 81.62 9.63

Price Performance

Historical Comparison
FUNC
TENX

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: